Evidence map›Paper›PMID 41991534›Full record

ArticleNature communications2026

Structure of a contractile injection system in Salmonella enterica subsp. salamae.

Rooshanie N Ejaz, Kristin Funke, Claudia S Kielkopf, Freddie J O Martin, Marta Šiborová, Ivo A Hendriks, Nicholas H Sofos, Tillmann Pape, Eva M Steiner-Rebrova, Michael L Nielsen and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rooshanie N EjazDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Kristin FunkeInstitute of Biology-Department of Molecular Microbiology, Humboldt-Universität zu Berlin, Berlin, Germany.ORCID http://orcid.org/0009-0007-0437-9301
Claudia S KielkopfDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-1360-4260
Freddie J O MartinDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-6456-2860
Marta ŠiborováDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-6879-5247
Ivo A HendriksNovo Nordisk Foundation Centre for Protein Research, ICMM, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-1439-3701
Nicholas H SofosNovo Nordisk Foundation Centre for Protein Research, ICMM, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Tillmann PapeNovo Nordisk Foundation Centre for Protein Research, ICMM, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-0612-3568
Eva M Steiner-RebrovaBiomedical Centre, Department of Experimental Medical Science, Faculty of Medicine, University of Lund, Lund, Sweden.ORCID http://orcid.org/0000-0001-8342-9520
Michael L NielsenDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Marc ErhardtInstitute of Biology-Department of Molecular Microbiology, Humboldt-Universität zu Berlin, 10115 Berlin, Max Planck Unit for the Science of Pathogens, Berlin, Germany.ORCID http://orcid.org/0000-0001-6292-619X
Nicholas M I TaylorDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. nicholas.taylor@sund.ku.dk.ORCID http://orcid.org/0000-0003-0761-4921

Funding

Det Frie Forskningsråd (Danish Council for Independent Research) 1030-00289B
6 · The paper itself

Abstract

Extracellular contractile injection systems (eCISs) are phage-derived nanomachines used by bacteria to deliver effectors into target cells. Well-studied examples include the Photorhabdus asymbiotica virulence cassettes and the antifeeding prophage from Serratia entomophila, which have been engineered for heterologous cargo delivery. Recent genomic analyses identified eCIS gene clusters in the opportunistic human pathogen Salmonella enterica subspecies salamae, but their structure, function, and biotechnological potential remain unexplored. Here, we report a high-resolution cryo-electron microscopy structure of the S. enterica eCIS. Our atomic models reveal a distinctive sheath architecture, an expansive cage-like shell around a central spike, and an associated integral membrane protein. We identify a putative effector encoded within the operon exhibiting mild periplasmic toxicity and provide evidence that the S. enterica eCIS deviates from canonical eCISs by interacting with the inner membrane. Guided by these structural features, we uncover, to the best of our knowledge, a previously unannotated cluster of contractile injection systems (CISs). Together, our findings expand the known diversity of CISs' structures and functions, and lay the groundwork for engineering customisable protein delivery platforms.

Indexed as

Bacterial ProteinsSalmonella entericaCryoelectron MicroscopyMultigene FamilyOperonBacterial Proteins

Identifiers

PMID41991534
PMCPMC13266070

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.